GlassScriptPhysician profile
Lewis J Tondo
NPI 1114922622
$441.88
in general payments reported to CMS, 2019-2025
9 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.95 · 2020: $136 · 2021: $44.48 · 2023: $76.82 · 2024: $19.52 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $296.76 | 2020-2025 | Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $24.28 | 2023 | Xarelto |
| Exact Sciences Corporation | $21.44 | 2023 | Cologuard Collection Kit |
| Eisai INC. | $19.30 | 2020 | |
| Ibsa Pharma INC. | $18.46 | 2020 | |
| Lilly USA, LLC | $17.09 | 2020 | |
| Genentech USA, INC. | $16.06 | 2021 | |
| Merck Sharp & Dohme LLC | $14.95 | 2019 | |
| Pfizer INC. | $13.54 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lewis Tondo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.